Jaundice at onset signifies a good prognosis in anti-D-associated HCV infection

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 1, 1997, Pages 77-79

  Sachithanandan, Sharmila ^a   Fielding, John Francis ^a,b  

^a BEAUMONT HOSPITAL   (Ireland)

^b MATER PRIVATE HOSPITAL   (Ireland)

Author keywords

Hepatitis C; Jaundice; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; RHESUS D ANTIBODY; VIRUS RNA;

AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HISTOLOGY; HUMAN; IMMUNOBLOTTING; JAUNDICE; LIVER BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031022364     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199701000-00018     Document Type: Article

References (15)

1. Dienstag JL: Hepatitis non-A non-B: C at last. Gastroenterology 1990, 99:1177-1180.
2. Alter MJ, Margoyles HS, Krawczyski K, Judson FN, Mares A, Alexander WJ, et al.: The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992, 327:1899-1905.
3. Alter MJ, Hadler SC, Judson FN: Risk factors for acute non-A non-B hepatitis in the United States and association with hepatitis C antibody. JAMA 1990, 264:2231-2235.
4. Young KKY, Resnick RM, Myers TW: Detection of hepatitis C virus RNA by a combined reverse transcriptase-polymerase chain reaction assay. J Clin Microbiol 1993, 31:882-886.
5. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al.: Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
6. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al.: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994, 19:1321-1324.
7. Alter HJ: Clinical, virological and epidemiological basis for the treatment of chronic non A-non B hepatitis. J Hepatol 1990, ii(suppl. 1):S19-S25.
8. McIntyre N: Clinical presentation of acute viral hepatitis. Br Med Bull 1990, 46:533-547.
9. Kiyosawa K, Akahane Y, Nagata A: Hepatocellular carcinoma after non A- non B post transfusional hepatitis. Am J Gastroenterol 1984, 79:777-781.
10. Seeff LB, Bales ZB, Wright EC, Durako SJ, Alter HJ, Iber FC, et al.: Long term mortality after transfusion associated non A, non B hepatitis. N Engl J Med 1992, 327:1906-1911.
11. Tanaka K, Hirohata T, Koga S, Takeshitas S, Sugimachi K, Kanematsu S, et al.: Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma - a case control study in Japan. Int J Cancer 1992, 51(4):505-514.
12. Mattsson L, Weilando O, Glaumann H: Longterm follow up of chronic post transfusional non-A non-B hepatitis: clinical and histological outcome. Liver 1988, 8:184-188.
13. Realdi G, Alter A, Rugge M, Rigoli AM, Tremolada F, Schivazagga C, et al.: Long term follow up of acute and chronic non A, non B post transfusional hepatitis: evidence of progression to liver cirrhosis. Gut 1982, 23:270-275.
14. Congress Abstract Review: International Symposium on viral hepatitis and liver disease. 8th Triennial Congress Tokyo, Japan May 1993, Abstract 3.
15. McHutchison JG, Kuo G, Houghton M, et al.: Hepatitis C virus antibodies in acute icteric and chronic non A non B hepatitis. Gastroenterology 1991, 101:1117-1119.